Cargando…

Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations

We sought to identify genes necessary to induce cytoskeletal change in B cells. Using gene expression microarray, we compared B cells stimulated with interleukin-4 (IL-4) and anti-CD40 antibodies that induce B cell spreading, cell motility, tight aggregates, and extensive microvilli with B cells sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerasimčik, Natalija, He, Minghui, Baptista, Marisa A. P., Severinson, Eva, Westerberg, Lisa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410582/
https://www.ncbi.nlm.nih.gov/pubmed/28507547
http://dx.doi.org/10.3389/fimmu.2017.00491
_version_ 1783232711857537024
author Gerasimčik, Natalija
He, Minghui
Baptista, Marisa A. P.
Severinson, Eva
Westerberg, Lisa S.
author_facet Gerasimčik, Natalija
He, Minghui
Baptista, Marisa A. P.
Severinson, Eva
Westerberg, Lisa S.
author_sort Gerasimčik, Natalija
collection PubMed
description We sought to identify genes necessary to induce cytoskeletal change in B cells. Using gene expression microarray, we compared B cells stimulated with interleukin-4 (IL-4) and anti-CD40 antibodies that induce B cell spreading, cell motility, tight aggregates, and extensive microvilli with B cells stimulated with lipopolysaccharide that lack these cytoskeletal changes. We identified 84 genes with 10-fold or greater expression in anti-CD40 + IL-4 stimulated B cells, one of these encoded the guanine nucleotide exchange factor (GEF) dedicator of cytokinesis 10 (Dock10). IL-4 selectively induced Dock10 expression in B cells. Using lacZ expression to monitor Dock10 promoter activity, we found that Dock10 was expressed at all stages during B cell development. However, specific deletion of Dock10 in B cells was associated with a mild phenotype with normal B cell development and normal B cell spreading, polarization, motility, chemotaxis, aggregation, and Ig class switching. Dock10-deficient B cells showed lower proliferation in response to anti-CD40 and IL-4 stimulation. Moreover, the IgG response to soluble antigen in vivo was lower when Dock10 was specifically deleted in B cells. Together, we found that most B cell responses were intact in the absence of Dock10. However, specific deletion of Dock10 in B cells was associated with a mild reduction in B cell activation in vitro and in vivo.
format Online
Article
Text
id pubmed-5410582
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54105822017-05-15 Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations Gerasimčik, Natalija He, Minghui Baptista, Marisa A. P. Severinson, Eva Westerberg, Lisa S. Front Immunol Immunology We sought to identify genes necessary to induce cytoskeletal change in B cells. Using gene expression microarray, we compared B cells stimulated with interleukin-4 (IL-4) and anti-CD40 antibodies that induce B cell spreading, cell motility, tight aggregates, and extensive microvilli with B cells stimulated with lipopolysaccharide that lack these cytoskeletal changes. We identified 84 genes with 10-fold or greater expression in anti-CD40 + IL-4 stimulated B cells, one of these encoded the guanine nucleotide exchange factor (GEF) dedicator of cytokinesis 10 (Dock10). IL-4 selectively induced Dock10 expression in B cells. Using lacZ expression to monitor Dock10 promoter activity, we found that Dock10 was expressed at all stages during B cell development. However, specific deletion of Dock10 in B cells was associated with a mild phenotype with normal B cell development and normal B cell spreading, polarization, motility, chemotaxis, aggregation, and Ig class switching. Dock10-deficient B cells showed lower proliferation in response to anti-CD40 and IL-4 stimulation. Moreover, the IgG response to soluble antigen in vivo was lower when Dock10 was specifically deleted in B cells. Together, we found that most B cell responses were intact in the absence of Dock10. However, specific deletion of Dock10 in B cells was associated with a mild reduction in B cell activation in vitro and in vivo. Frontiers Media S.A. 2017-05-01 /pmc/articles/PMC5410582/ /pubmed/28507547 http://dx.doi.org/10.3389/fimmu.2017.00491 Text en Copyright © 2017 Gerasimčik, He, Baptista, Severinson and Westerberg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Gerasimčik, Natalija
He, Minghui
Baptista, Marisa A. P.
Severinson, Eva
Westerberg, Lisa S.
Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title_full Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title_fullStr Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title_full_unstemmed Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title_short Deletion of Dock10 in B Cells Results in Normal Development but a Mild Deficiency upon In Vivo and In Vitro Stimulations
title_sort deletion of dock10 in b cells results in normal development but a mild deficiency upon in vivo and in vitro stimulations
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410582/
https://www.ncbi.nlm.nih.gov/pubmed/28507547
http://dx.doi.org/10.3389/fimmu.2017.00491
work_keys_str_mv AT gerasimciknatalija deletionofdock10inbcellsresultsinnormaldevelopmentbutamilddeficiencyuponinvivoandinvitrostimulations
AT heminghui deletionofdock10inbcellsresultsinnormaldevelopmentbutamilddeficiencyuponinvivoandinvitrostimulations
AT baptistamarisaap deletionofdock10inbcellsresultsinnormaldevelopmentbutamilddeficiencyuponinvivoandinvitrostimulations
AT severinsoneva deletionofdock10inbcellsresultsinnormaldevelopmentbutamilddeficiencyuponinvivoandinvitrostimulations
AT westerberglisas deletionofdock10inbcellsresultsinnormaldevelopmentbutamilddeficiencyuponinvivoandinvitrostimulations